IL23A and inflammatory bowel disease: Given the association between pathological IL-23R signaling and IBD, and the observation that IL-23-derived Th17 immunity promotes IgG class-switching and inflammatory glycosyl patterns (267), these pathways may reinforce one another for the augmentation of pathology in the GI tract.